Elevated sputum azurocidin-1 levels correlate with worsening lung function and increased exacerbation frequency in patients with bronchiectasis.

Bronchiectasis is a heterogeneous condition and may be encountered as a stand-alone pulmonary disease by primary care clinicians and specialists in pulmonary medicine. Bronchiectasis sometimes ...

A medical expert highlights the impact of bronchiectasis diagnosis on quality of life for patients and their caregivers. Bronchiectasis complications include frequent exacerbations, interfering with ...

Bronchiectasis is a chronic condition of the respiratory system, in which there is abnormal widening of the airways due to an initial damaging factor. This in turn reduces the ability of the bronchi ...

At the event in Hanover, patients can look forward to lectures, workshops, and practical tips. They will have the opportunity to exchange ideas with experts and connect with other patients. The MHH is ...

As the first-to-market DPP-1 inhibitor, Brinsupri is on course to become the standard of care in bronchiectasis treatment.

Bronchiectasis is a chronic condition of the respiratory system that is due to abnormal widening of the airways as a consequence of an initial damaging factor. The bronchi, located between the trachea ...

BRONCHIECTASIS is protean in its expressions as it is sometimes obscure in its origin. The clinical picture varies in individual patients, but common to the severer cases is a history of harassing, ...